Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030182 | SCV000052846 | benign | Familial Mediterranean fever | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Benign. |
Prevention |
RCV000242621 | SCV000303123 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000242621 | SCV000331351 | benign | not specified | 2015-12-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000030182 | SCV000396784 | benign | Familial Mediterranean fever | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
ARUP Laboratories, |
RCV001355595 | SCV000604164 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000030182 | SCV001717597 | benign | Familial Mediterranean fever | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001533779 | SCV001750598 | benign | Familial Mediterranean fever, autosomal dominant | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000030182 | SCV001750599 | benign | Familial Mediterranean fever | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001355595 | SCV001890283 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002262588 | SCV002543752 | benign | Autoinflammatory syndrome | 2016-12-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002444447 | SCV002753038 | benign | Inborn genetic diseases | 2016-10-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Unidad de Genómica Garrahan, |
RCV000242621 | SCV004102607 | benign | not specified | 2023-11-12 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 88% of patients studied by a panel of primary immunodeficiencies. Number of patients: 84. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001355595 | SCV005293874 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000030182 | SCV001457159 | benign | Familial Mediterranean fever | 2020-09-16 | no assertion criteria provided | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001355595 | SCV001550522 | uncertain significance | not provided | no assertion criteria provided | clinical testing | Allele frequency is common in at least one population database (frequency: 61.662% in ExAC) based on the frequency threshold of 1.904% for this gene. Variant was observed in a homozygous state in population databases more than expected for disease. A synonymous variant not located in a splice region. | |
Diagnostic Laboratory, |
RCV000242621 | SCV001743944 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000242621 | SCV001932466 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome |
RCV001355595 | SCV002074701 | not provided | not provided | no assertion provided | phenotyping only | Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. |